NMN Conference, April 26-27, 2024 – Vienna, Austria

We would like to inform you that the registration to the first Symposium on „Diagnostic and Therapeutic Innovations in the Era of Precision Medicine – Nuclear Medicine Meets Neuro-Oncology“ to be held on April 26-27th 2024 in Vienna is now open.

You can find all information including the full program and the registration page here: https://www.nmn-society.org/.

Please also note that you can sign up for their newsletter to receive updates regarding the meeting. 

The NMN symposium aims to provide a highly interactive platform for scientific and educational exchange on the fascinating and clinically highly relevant aspects in research and application of nuclear medicine with a focus on malignancies of the central nervous system (CNS). Primary and secondary CNS tumors represent a particularly challenging and heterogenous disease entity, which is also characterized by a multitude of molecular alterations. Nuclear medicine is of particular relevance and carries an exceptionally high potential for improvements of diagnosis, molecular classification, planning of therapeutic interventions (neurosurgery, radiotherapy, targeted therapy, immunotherapy), assessment of therapy response and drug development (including assessment of blood-brain barrier penetration) in the field of Neuro-Oncology.

Nathalie Albert & Matthias Preusser

Scientific Committee:
Nathalie L. Albert, Munich
Matthias Preusser, Vienna
Martin van den Bent, Rotterdam
Michael Weller, Zurich
Jolanta Kunikowska, Warsaw
Emilie Le Rhun, Zurich
Norbert Galldiks, Cologne
Marcus Hacker, Vienna
Giuseppe Minniti, Rome
Karl Rössler, Vienna
Nelleke Tolboom, Utrecht
Francesco Cicone, Catanzaro
Anna Berghoff, Vienna